KPRX Projected Dividend Yield
Com Par $0.01/Kiora Pharmaceuticals Inc ( NASDAQ : KPRX )Kiora Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. Co. is focused on developing and commercializing therapies for the treatment of orphan retinal diseases. Its pipeline consists of three product candidates, including KIO-301, KIO-104, KIO-101 and KIO-201. Its lead product, KIO-301, is a vision-restoring small molecule that is designed to restore vision in patients with inherited and age-related degenerative retinal diseases, including retinitis pigmentosa (RP). 21 YEAR PERFORMANCE RESULTS |
KPRX Dividend History Detail KPRX Dividend News KPRX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |